View allArchimedPortfolio companyPress clippings

2021/01/25 | Press Release – ArchiMed’s BOMI Group enters new geographies and market segments through six Buy-and-Build acquisitions made over eight months

The aggressive, ongoing acquisition program is consolidating a fragmented industry and turning BOMI into a full-service, one-stop shop for international healthcare logistics. January 25, 2021 – Through six acquisitions carried out between May, 2020 and January, 2021, healthcare logistics specialist BOMI Group is adding some 20 percent to its annual revenues. Going forward, annual revenues are…

MORE

2021/01/25 | Press Release – ArchiMed’s Direct Healthcare Group sees annual revenue more than double through four Buy-and-Build purchases over nine months

The transactions – with more in the pipeline – put DHG on course to be the leading pan-European provider of products and solutions for the care of patients with limited mobility. January 25, 2021 – Direct Healthcare Group, a majority-owned portfolio company (and partner) of private equity healthcare specialist ArchiMed, increased its annual revenues in 2020…

MORE

2020/04/09 | Press Release – ArchiMed’s Direct Healthcare Group acquires Patient Handling Europe

The purchase by DHG – a portfolio company of European private equity health care specialist ArchiMed – is a carve-out from Swedish-listed group Handicare. European private equity healthcare specialist, ArchiMed announces that its portfolio company and partner Direct Healthcare Group has acquired the Patient Handling Europe division of Swedish-listed group Handicare. The acquisition deepens DHG’s…

MORE

2020/03/23 | Press Release – ArchiMed portfolio company Diesse is developing a blood test for COVID-19 detection – it will be one of the first in the world capable of accurately mapping the spread of the virus

Scheduled for distribution in late April, the test indicates whether someone has ever had COVID-19 or is a carrier without symptoms; testing today commonly shows only whether someone displaying symptoms actually has COVID-19. Leading in vitro diagnostics specialist – and ArchiMed portfolio company – Diesse Diagnostica Senese, based in Siena, Italy, has developed one of…

MORE

2020/03/03 | Press Release – ArchiMed’s DHG completes its first non-UK acquisition, buying Sweden’s GATE Rehab Development AB

This is DHG’s first buy-and-build transaction since its purchase by leading European private equity healthcare specialist, ArchiMed in December. More buy-and-build transactions for DHG – part of ArchiMed’s portfolio of partnering companies – in continental Europe will follow. GATE Rehab Development AB, based in Reftele, Sweden, has extensive experience as a cutting edge researcher, designer…

MORE